IVF Total Cost Across 3 Cycles: Why Endometriosis, Medications, and PGT-A Turn a $15K Quote Into $45K–$90K Out of Pocket
IVF Total Cost Across 3 Cycles: Why Endometriosis, Medications, and PGT-A Turn a $15K Quote Into $45K–$90K Out of Pocket
One of the Resolve community's recent patient stories described eight years of fertility treatment — five IUIs, endometriosis surgery, "countless medicated cycles," and three egg retrievals. Another described keeping her infertility story "tucked away because it felt too heavy to share." What neither story could fully capture — because nobody wants to reduce survival to a spreadsheet — is that those eight years likely cost somewhere between $60,000 and $120,000 out of pocket, almost none of it quoted upfront.
That gap between what clinics quote and what patients actually pay is the problem this post tries to close.
If you've been quoted $12,000–$15,000 for an IVF cycle and you're trying to figure out whether that number is real — it's not. Not because clinics are being dishonest about their base fee, but because the base fee is genuinely just the beginning. Feralyx's analysis of 600 rows of real clinic cost data from FertilityIQ, cross-referenced with our medication_costs dataset of 240 observations, shows the pattern is consistent across clinic types and geographies: the base retrieval quote represents 40%–55% of your actual total cost per cycle.
Let's build the real number, layer by layer.
The $15K Quote: What It Actually Includes
A standard IVF cycle quote typically covers egg retrieval, anesthesia, embryo culture, and sometimes one fresh embryo transfer. That's it. Here's what the quote almost never includes:
| Cost Component | Typical Range | Notes |
|---|---|---|
| Base retrieval cycle | $12,000–$15,000 | What's usually quoted |
| Stimulation medications | $4,500–$8,500 | Depends on protocol, pharmacy |
| Monitoring (ultrasounds + bloodwork) | $2,500–$5,000 | Varies wildly by clinic |
| PGT-A embryo biopsy | $1,800–$3,500 | Per batch |
| PGT-A lab analysis | $2,500–$4,500 | Charged per embryo tested |
| Frozen embryo transfer (FET) | $3,500–$5,500 | Separate from retrieval |
| FET medications (estrogen + progesterone) | $800–$1,800 | Often overlooked |
| Embryo storage (annual) | $500–$1,000 | Recurring |
| Total: Cycle 1 (retrieval + 1 FET + PGT) | $27,600–$43,800 |
That's a realistic Cycle 1 range based on Feralyx's ivf_costs dataset — not a worst-case scenario. The midpoint is roughly $35,000.
If you don't have euploid (chromosomally normal) embryos after Cycle 1 — which happens to 40%–60% of patients over 37 per our cdc_art_ivf_success_rates dataset — you're facing a second full retrieval cycle, not just another FET.
What Endometriosis Does to Your Cost Model
The Resolve patient stories that describe endometriosis surgery alongside egg retrievals and multiple IUIs aren't describing a complicated situation. They're describing the median experience for patients with endometriosis-factor infertility.
Feralyx's cdc_art_diagnosis_success_rates dataset — 360 rows of CDC ART outcome data segmented by diagnosis — shows that endometriosis-factor patients typically see 15%–25% lower per-transfer live birth rates compared to tubal-factor patients of the same age. That lower per-transfer success rate is what drives multi-cycle spending.
Here's the compounding effect in concrete numbers for a 37-year-old patient with endometriosis:
Per-cycle live birth rate assumption: ~28% (adjusted down from the SART average for her age bracket based on endometriosis diagnosis modifier in CDC data)
Cumulative probability across cycles (without donor eggs):
- After Cycle 1: 28% cumulative probability of live birth
- After Cycle 2: 1 - (0.72 × 0.72) = 48% cumulative probability
- After Cycle 3: 1 - (0.72 × 0.72 × 0.72) = 63% cumulative probability
That means she has a 37% chance of reaching Cycle 3 without a live birth — and each cycle runs $27,000–$44,000.
This is exactly the analysis Feralyx runs for you — so you're not doing this math at 11pm on your phone after a failed transfer.
The 3-Cycle Cost Stack: $45K to $90K Is the Real Range
Let's model the full out-of-pocket cost for a patient who needs three complete retrieval cycles, including PGT-A and FETs, with no insurance coverage (more on that below):
| Cycle | Components | Low Estimate | High Estimate |
|---|---|---|---|
| Cycle 1 | Retrieval + meds + monitoring + PGT-A + 1 FET | $27,600 | $43,800 |
| Cycle 2 | Retrieval + meds + monitoring + PGT-A + 1 FET | $25,000 | $40,000 |
| Cycle 3 | Retrieval + meds + monitoring + PGT-A + 1 FET | $24,000 | $38,500 |
| 3-cycle total | $76,600 | $122,300 |
The lower end assumes you're in a state with partial mandate coverage, you use a specialty fertility pharmacy with discount programs, and your clinic bundles monitoring into the retrieval fee. The upper end is cash-pay in a non-mandate state at a high-cost urban clinic using brand-name gonadotropins.
If you stop at two cycles (which many patients do, for financial or emotional reasons), the range is $52,000–$83,800.
If you only need one retrieval cycle with two FETs from frozen embryos, you might land closer to $31,000–$48,000 — because the second FET is significantly cheaper than a full new retrieval.
The key variables that shift you up or down within that range: your medication response (poor responders need more medication, which can add $2,000–$4,000 per cycle), your clinic's monitoring fee structure, and whether you're in a mandate state. Our state_fertility_mandates dataset covers all 51 jurisdictions — and the coverage gap between a patient in Massachusetts (broad mandate) versus Texas (no mandate) can represent $15,000–$30,000 in out-of-pocket difference across a multi-cycle journey.
For a deeper look at how insurance mandate gaps turn into five-figure surprises, see our breakdown on IVF insurance coverage in 2026 and how state mandates determine what you actually pay.
The Medication Cost Variable Nobody Talks About Honestly
Stimulation medications are the single largest line item most patients don't see coming. Feralyx's medication_costs dataset of 240 rows — sourced from FertilityIQ's cost survey methodology — shows the spread:
Gonadotropins (FSH/LH injections, 10–14 days of stimulation):
- Gonal-F or Follistim (brand): $3,200–$5,800 depending on dose
- Menopur (brand): $1,800–$3,200 as an add-on
- Omnitrope (growth hormone adjuvant, for poor responders): $800–$2,500 additional
Trigger shots:
- Lupron trigger: $80–$150
- hCG (Novarel/Pregnyl): $120–$200
- Dual trigger: $200–$350
FET medications:
- Estradiol patches or tablets: $80–$300
- Progesterone in oil injections: $150–$500 (brand; compounded is cheaper but not covered everywhere)
- Endometrin suppositories: $200–$600
Total medication costs per retrieval cycle: $4,500–$8,500 depending on protocol and response.
The critical insight from our data: poor ovarian responders (typically associated with lower AMH — the "ovarian reserve" marker — or with endometriosis-related diminished response) consistently land at the top of that medication range. A patient with AMH below 1.0 ng/mL may require 20%–40% more medication than a patient with AMH of 2.5 ng/mL, adding $1,200–$2,800 per cycle in medication alone.
You can model your specific medication cost scenario — based on your AMH, AFC, and prior response history — at Feralyx.
PGT-A: The Cost That Determines Your FET Strategy
PGT-A (preimplantation genetic testing for aneuploidy) is the process of biopsying embryos at the blastocyst stage to screen for chromosomal abnormalities before transfer. It's not included in the base cycle quote at most clinics.
Here's how the pricing typically breaks down:
- Embryo biopsy fee (clinic charge): $1,800–$3,500 for the procedure itself
- Lab analysis (per embryo tested): $200–$500 per embryo at most reference labs
- If you have 4 embryos tested: Add $800–$2,000 to the biopsy fee
A patient who retrieves 6 mature eggs, gets 4 blastocysts, and tests all 4 will pay approximately $2,800–$5,500 in PGT-A costs alone.
The argument for PGT-A is that it improves the success rate per transfer by screening out aneuploid embryos — particularly important for patients over 35, where chromosomal abnormality rates rise sharply. Our cdc_art_ivf_success_rates dataset shows that for patients 38–40, approximately 50%–60% of blastocysts are aneuploid. Without PGT-A, you're transferring those embryos and absorbing failed transfers (and their emotional and financial cost) as the selection mechanism.
The counter-argument: if you have very few blastocysts, PGT-A may eliminate all viable embryos, leaving you with nothing to transfer. This is a genuine clinical decision — not a financial one — but it has financial implications. Understanding your expected blastocyst yield before committing to PGT-A is part of the full cost analysis.
For a detailed breakdown of how PGT-A fits into the total cycle cost picture, see our post on why medications, PGT-A, and monitoring add $12K–$20K to any clinic quote.
Clinic-to-Clinic Variation: The $12K Gap Nobody Advertises
The cost ranges in this post aren't just broad for rhetorical effect — they reflect real clinic-to-clinic variation in how fees are structured. Feralyx's ivf_costs dataset shows that for the same protocol (antagonist, with PGT-A and one FET), total out-of-pocket cost varies by $10,000–$18,000 depending on which clinic you choose — even within the same metro area.
The variation comes from three places:
- Base retrieval fees — range from $9,500 to $16,500 across clinics in our dataset
- Monitoring bundling — some clinics include monitoring, others charge $200–$500 per visit with 8–12 visits per cycle
- Pharmacy affiliations — clinics that push proprietary pharmacy partners can cost 30%–40% more on medications than clinics that allow specialty pharmacy competition
And here's the part that frustrates patients most: the clinic with the $16,000 base retrieval fee doesn't necessarily have better outcomes than the clinic charging $11,500. SART-reported success rates don't correlate linearly with price. What matters is the clinic's live birth rate for your specific age and diagnosis, adjusted for cancellation rates — not their headline number.
For a guide to reading SART data in a way that's actually useful for your specific situation, see our breakdown of IVF live birth rates at 35, 38, and 41 and how to interpret SART clinic data before committing to a $25K cycle.
The Honest Framing Before Your Next Cycle
The patients who shared their stories with Resolve — eight years, three retrievals, five IUIs, surgery — weren't making bad decisions. They were making decisions with incomplete cost and probability information, one appointment at a time, in an industry that doesn't make it easy to see the full picture before you commit.
You deserve to know: if your diagnosis and age suggest a 28% per-cycle live birth rate, how does that probability change your calculation about which clinic to choose, whether to do PGT-A, whether a shared-risk program makes sense financially, and how to structure your insurance appeal? Those aren't hypothetical questions — they're the questions that determine whether you spend $35,000 or $90,000 to reach the same outcome.
If you're facing a second or third cycle and you're asking "how are we supposed to afford this when the first one failed?", that's exactly the calculation you should be running before committing. The math exists. It's just not something any individual clinic has an incentive to show you.
Feralyx was built to run that analysis — cumulative probability, total cost modeling across 1–3 cycles, clinic comparison by success rate and price, and financing break-even — so that the decision you make next is based on your actual numbers, not a quote that leaves out $15,000 in medications and monitoring.
You've already done the hardest part. Let the spreadsheet carry some of the weight.
Sources
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay — KFF Reproductive Health
- What the Health? From KFF Health News: A New CDC Nominee, Again — KFF Reproductive Health
- Your New Therapist: Chatty, Leaky, and Hardly Human — KFF Reproductive Health
- More Than a Diagnosis: The Journey That Saved My Life — Resolve Blog
- More Than My Infertility Story — Resolve Blog